Coronavirus: Restrictions imposed on some APIs, says Union Minister Mandaviya Medical Dialogues Bureau7 March 2020 7:39 AM GMTIn the case of some APIs, a crisis may occur in the country in the future, if they are exported
Europe 'panicking' over India's pharmaceutical export curbs - Pharmexcil Medical Dialogues Bureau6 March 2020 9:40 AM GMTThe list of restricted medicines accounts for 10% of India's total pharmaceutical exports and includes several antibiotics, as well as Paracetamol, a...
Need to reduce dependency on API imports: Minister appeals to Pharma Companies Medical Dialogues Bureau5 March 2020 11:37 AM GMTGeneric medicines sold at dedicated Jan Aushadhi stores are cheaper by at least 50% and for some even by 90%.
IDMA warns of adverse impact of coronavirus on Indian Pharma Companies Medical Dialogues Bureau5 March 2020 7:43 AM GMTThere is no immediate short-term impact of coronavirus but this may change if the epidemic drags on
Govt Bans Export of Paracetemol, vitamins, and other key drugs, details Medical Dialogues Bureau4 March 2020 6:08 AM GMTThe ban comes into force immediately and will continue till further orders
Biocon Small Molecules API Manufacturing Facility Completes Post -Approval and GMP USFDA Inspection Medical Dialogues Bureau29 Feb 2020 6:05 AM GMTNew Delhi: Drug API maker, Biocon has informed that the U.S. Food and Drug Administration (FDA) conducted a Post-Approval and GMP inspection of Small...
Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details Medical Dialogues Bureau28 Feb 2020 10:56 AM GMTNew Delhi: In the light of coronavirus outbreak worldwide, the apex drug regulator National Pharmaceutical Pricing Authority (NPPA) has identified 58...
Minister informs Parliament about steps taken to promote affordable generic drugs Medical Dialogues Bureau26 Nov 2019 11:00 AM GMTNew Delhi: The Minister in the Ministry of Chemicals and Fertilizers D V Sadananda Gowda recently informed the Parliament about the steps taken by the...
Dr Reddys Srikakulam plant gets 4 USFDA observations Farhat Nasim29 Oct 2019 4:30 AM GMTThe audit of Dr Reddy's API Srikakulam Plant (SEZ) by the United States Food and Drug Administration (USFDA) was completed on Friday, the...
Cadila Healthcare largest API manufacturing site clears USFDA inspection Medical Dialogues Bureau12 Oct 2019 6:11 AM GMTThe US Food and Drug Administration (USFDA) inspected the company's active pharmaceutical ingredients (API) manufacturing facility at Dabhasa from...
Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA Medical Dialogues Bureau11 Oct 2019 4:30 AM GMT"The responsibilities and procedures applicable to the quality control unit are not fully followed. Several lists of documents requested were either...
Mylan to infuse USD 1 billion on capex in India Medical Dialogues Bureau30 Sep 2019 4:00 AM GMTMylan Global President and Executive Director Rajiv Malik said the company had been investing close to about USD 400 million or USD 450 million...
